Nine patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Aug 2038. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Aug 2038
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2019 to 2043.
US 11,344,518
Method of Converting Atrial Fibrillation to Normal Sinus Rhythm and Loading Oral Sotalol in a Shortened Time Frame
Aug 14, 2038
US 12,763,186
Antiarrhythmic Drug Dosing Methods and Systems and Prescription Drug Use Related Software
Jul 4, 2043
20242029203420392043
18 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 11, 2027The maintenance fee for Method of Initiating and Escalating Sotalol Hydrochloride Dosing (US 11,696,902) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 1 fee due Jun 24, 2027The maintenance fee for Method of Initiating and Escalating Sotalol Hydrochloride Dosing (US 10,512,620) comes due Jun 24, 2027. Unpaid by Dec 27, 2027, it lapses early.
Recent changes
- Oct 20Assignment recorded on 1 record: Punt, Niekolaas Coert and 3 others to Altathera Pharmaceuticals LLC Recorded Oct 20, 2026, executed Oct 16, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76438, frame 865.
- Sep 25Assignment recorded on 5 records: Kashfian, Brandon Ira to Altathera Pharmaceuticals LLC Recorded Sep 25, 2026, executed Sep 23, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76152, frame 342.
- 2 of the patents on this record were granted since Aug 17, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Method of Initiating and Escalating Sotalol Hydrochloride Dosing | 9 in force | to Jul 2043 |
Patents held now
Soonest term end first.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,512,620 | Method of Initiating and Escalating Sotalol Hydrochloride Dosing In force · High confidence | In force | High confidence | |
| US 11,344,518 | Method of Converting Atrial Fibrillation to Normal Sinus Rhythm and Loading Oral Sotalol in a Shortened Time Frame In force · High confidence | In force | High confidence | |
| US 11,696,902 | Method of Initiating and Escalating Sotalol Hydrochloride Dosing In force · High confidence | In force | High confidence | |
| US 12,390,431 | Method of Escalating Sotalol Hydrochloride Dosing In force · High confidence | In force | High confidence | |
| US 12,403,109 | Sotalol Hydrochloride Dosing In force · High confidence | In force | High confidence | |
| US 12,740,947 | Method of Initiating Sotalol Hydrochloride Dosing In force · High confidence | In force | High confidence | |
| US 11,610,660 | Antiarrhythmic Drug Dosing Methods, Medical Devices, and Systems In force · High confidence | In force | High confidence | |
| US 12,396,970 | Anti-Arrhythmic Compositions and Methods In force · High confidence | In force | High confidence | |
| US 12,763,186 | Antiarrhythmic Drug Dosing Methods and Systems and Prescription Drug Use Related Software In force · High confidence | In force | High confidence |
Also on record, not counted in the 9: 18 applications pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.